Abnormal/JJ
regulation/NN
of/IN
the/DT
IL-2/NN
promoter/NN
in/IN
lpr/NN
CD4-CD8- T/NN
lymphocytes/NNS
results/VBZ
in/IN
constitutive/JJ
expression/NN
of/IN
a/DT
novel/JJ
nuclear/JJ
factor/NN
of/IN
activated/VBN
T/NN
cells-binding/JJ
factor/NN
./.

The/DT
inert/JJ
quality/NN
of/IN
MRL-Ipr/Ipr/NN
(/(
Ipr/NN
)/)
peripheral/JJ
CD4-CD8-/JJ
(/(
CD4-8-/NN
)/)
T/NN
cells/NNS
manifests/VBZ
primarily/RB
as/IN
an/DT
inability/NN
to/TO
proliferate/VB
or/CC
produce/VB
IL-2/NN
in/IN
response/NN
to/TO
TCR/NN
or/CC
mitogenic/JJ
stimulation/NN
./.
=====
Yet/RB
these/DT
same/JJ
cells/NNS
do/VBP
initiate/VB
early/JJ
TCR-mediated/JJ
signaling/NN
events/NNS
,/,
such/JJ
as/IN
generation/NN
of/IN
inositol/JJ
phosphates/NNS
and/CC
increased/VBN
intracellular/JJ
calcium/NN
./.
=====
They/PRP
also/RB
display/VBP
constitutively/RB
high/JJ
levels/NNS
of/IN
p59fyn/NN
and/CC
CD3/NN
zeta/NN
tyrosine/NN
phosphorylation/NN
./.
=====
The/DT
generation/NN
of/IN
second/JJ
messengers/NNS
in/IN
T/NN
cells/NNS
normally/RB
leads/VBZ
to/TO
downstream/JJ
signaling/NN
that/WDT
results/VBZ
in/IN
transcriptional/JJ
activation/NN
of/IN
the/DT
IL-2/NN
gene/NN
./.
=====
We/PRP
,/,
therefore/RB
,/,
compared/VBD
the/DT
activation/NN
state/NN
of/IN
the/DT
IL-2/NN
gene/NN
promoter/NN
region/NN
in/IN
freshly/RB
isolated/VBN
and/CC
stimulated/VBN
Ipr/NN
CD4-8-T/NN
cells/NNS
with/IN
that/DT
of/IN
normal/JJ
T/NN
lymphocytes/NNS
./.
=====
Levels/NNS
of/IN
the/DT
octamer/NN
,/,
NF-kappa/NN
B/NN
(/(
p50-p65/NN
heterodimer/NN
)/)
,/,
and/CC
AP-1/NN
transcriptional/JJ
factors/NNS
are/VBP
constitutively/RB
elevated/VBN
in/IN
freshly/RB
isolated/VBN
Ipr/NN
CD4-8-T/NN
cells/NNS
,/,
consistent/JJ
with/IN
the/DT
activated/VBN
phenotype/NN
of/IN
these/DT
cells/NNS
./.
=====
Upon/IN
stimulation/NN
with/IN
mitogens/NNS
,/,
formation/NN
of/IN
the/DT
transactivating/VBG
complex/NN
,/,
nuclear/JJ
factor/NN
of/IN
activated/VBN
T/NN
cells/NNS
(/(
NF-AT/NN
)/)
,/,
occurs/VBZ
with/IN
normal/JJ
kinetics/NNS
in/IN
Ipr/NN
CD4-8-T/NN
cells/NNS
./.
=====
Yet/RB
,/,
the/DT
levels/NNS
of/IN
the/DT
activating/VBG
NF-AT/NN
complex/NN
never/RB
reach/VBP
those/DT
observed/VBN
in/IN
similarly/RB
stimulated/VBN
normal/JJ
T/NN
cells/NNS
./.
=====
Furthermore/RB
,/,
nuclear/JJ
extracts/NNS
from/IN
Ipr/NN
CD4-8-T/NN
cells/NNS
display/VBP
high/JJ
levels/NNS
of/IN
a/DT
novel/JJ
specific/JJ
binding/NN
activity/NN
at/IN
the/DT
NF-AT/NN
site/NN
,/,
which/WDT
is/VBZ
present/JJ
at/IN
much/JJ
lower/JJR
levels/NNS
in/IN
freshly/RB
isolated/VBN
normal/JJ
T/NN
lymphocytes/NNS
./.
=====
Upon/IN
mitogenic/JJ
stimulation/NN
,/,
the/DT
binding/NN
activity/NN
of/IN
the/DT
novel/JJ
NF-AT-binding/JJ
factor/NN
is/VBZ
rapidly/RB
down-regulated/VBN
in/IN
normal/JJ
T/NN
cells/NNS
,/,
but/CC
persists/VBZ
at/IN
high/JJ
levels/NNS
in/IN
Ipr/NN
CD4-8-T/NN
cells/NNS
./.
=====
These/DT
two/CD
abnormalities/NNS
at/IN
the/DT
NF-AT/NN
site/NN
provide/VBP
a/DT
potential/JJ
mechanism/NN
to/TO
account/VB
for/IN
the/DT
defect/NN
in/IN
IL-2/NN
production/NN
from/IN
Ipr/NN
CD4-8-T/NN
cells/NNS
./.